Caricamento...
Immune Effects of Bevacizumab: Killing Two Birds with One Stone
Angiogenesis or new vessel formation is essential for tumour growth and progression. Therefore, targeting angiogenesis has been an attractive strategy in the treatment ofcancer. Bevacizumab is a recombinant humanized monoclonal IgG1 antibody thattargets vascular endothelial growth factor-A (VEGF-A)...
Salvato in:
| Pubblicato in: | Cancer Microenviron |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Netherlands
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4449343/ https://ncbi.nlm.nih.gov/pubmed/25326055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12307-014-0160-8 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|